These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3825695)

  • 1. Long-term course in Parkinson's syndrome and cerebral polypathy (Parkinson plus).
    Fischer PA
    Adv Neurol; 1987; 45():235-8. PubMed ID: 3825695
    [No Abstract]   [Full Text] [Related]  

  • 2. Levodopa treatment of Parkinson's syndrome: past and future.
    Pletscher A
    Adv Neurol; 1990; 53():469-73. PubMed ID: 2239486
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term effect of levodopa on progression of Parkinson's disease.
    Webster DD; Mortimer JA; Kuskowski MA
    Adv Neurol; 1987; 45():473-6. PubMed ID: 3103390
    [No Abstract]   [Full Text] [Related]  

  • 4. [The apomorphine test for diagnosis of parkinsonian syndrome].
    Piccini P; Del Dotto P; Napolitano A; Pardini C; Bonuccelli U
    Riv Neurol; 1990; 60(6):221-3. PubMed ID: 2100046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
    Imai H; Nakamura T; Kondo T; Narabayashi H
    Adv Neurol; 1993; 60():622-5. PubMed ID: 8420201
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinson's disease before age 30.
    Lima AB; Levy A; Caldas AC; Neves G; Lopes G; Sampaio C
    Adv Neurol; 1993; 60():553-7. PubMed ID: 8420190
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia.
    Narabayashi H; Kondo T; Yokochi F; Nagatsu T
    Adv Neurol; 1987; 45():593-602. PubMed ID: 3103397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results after 3 to 5 years of treatment of 219 cases of Parkinson's syndrome treated by L-Dopa and an L-Dopa -decarboxylase inhibitor combination].
    Boudin G; Pepin B; Guillard A; Godlewski S; Fabiani JM; Haguenau M
    Rev Neurol (Paris); 1974; 130(7-8):273-84. PubMed ID: 4217929
    [No Abstract]   [Full Text] [Related]  

  • 9. Nosological concept of juvenile parkinsonism with reference to the dopa-responsive syndrome.
    Yokochi M
    Adv Neurol; 1993; 60():548-52. PubMed ID: 8420189
    [No Abstract]   [Full Text] [Related]  

  • 10. L-deprenyl in the treatment of Parkinson's disease.
    Csanda E; Tárczy M; Takáts A; Mogyorós I; Köves A; Katona G
    J Neural Transm Suppl; 1983; 19():283-90. PubMed ID: 6421993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.
    Benbir G; Ozekmekçi S; Apaydin H; Delil S; Erginöz E
    Clin Neurol Neurosurg; 2006 Dec; 108(8):726-32. PubMed ID: 16564615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
    Montastruc JL; Fabre N; Blin O; Senard JM; Rascol O; Rascol A
    Mov Disord; 1995 May; 10(3):355-7. PubMed ID: 7651460
    [No Abstract]   [Full Text] [Related]  

  • 13. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
    Merello M; Nouzeilles MI; Arce GP; Leiguarda R
    Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case studies in the advancement of Parkinson's disease.
    Frei K; Truong DD; Wolters E
    CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term results of continuous subcutaneous apomorphine pump therapy in patients with advanced Parkinson disease].
    Kreczy-Kleedorfer B; Wagner M; Bösch S; Poewe W
    Nervenarzt; 1993 Apr; 64(4):221-5. PubMed ID: 8506009
    [No Abstract]   [Full Text] [Related]  

  • 16. The levodopa test in Parkinson's disease.
    D'Costa DF; Sheehan LJ; Phillips PA; Moore-Smith B
    Age Ageing; 1995 May; 24(3):210-2. PubMed ID: 7645440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations made with L-deprenil (Jumex) in the long-term treatment of outpatients with Parkinson's syndrome.
    Gyimóti G; Csanaky A; Leposa D
    Ther Hung; 1983; 31(1):26-30. PubMed ID: 6443750
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinson's disease and related syndromes.
    Weiner WJ
    Med Sect Proc; 1993; ():195-203. PubMed ID: 8078870
    [No Abstract]   [Full Text] [Related]  

  • 19. Research diagnostic criteria for Parkinson's disease.
    Ward CD; Gibb WR
    Adv Neurol; 1990; 53():245-9. PubMed ID: 2239463
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modification of disturbed visual-spatial performance in patients with Parkinson's disease by treatment with L-dopa].
    Jacobi P; Schneider E; Gundelsheimer W; Fischer PA
    Nervenarzt; 1974 Nov; 45(11):588-94. PubMed ID: 4453348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.